Rare diseases
Investigational molecules
Locations
Back to Hungary42 clinical trials in Baja, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
HungaryA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
HungaryA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
HungaryA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
HungaryStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
HungaryStudy of ISIS 678354 for Patients with Severe High Triglycerides
HungaryStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
HungaryStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
HungaryStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
HungaryStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
HungaryStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Studies evaluate new therapies for preventing major cardiovascular events and improving patient outcomes.
Current research includes evaluation of novel compounds like pelacarsen and obicetrapib for reducing cardiovascular risks.
Comprehensive studies addressing type 2 diabetes and obesity, with trials testing innovative therapeutic approaches for better disease management and improved patient outcomes.
Investigations include new combination therapies and treatment options for patients with inadequate response to current medications.
Innovative trials examining treatments for chronic kidney disease and associated conditions, including specialized therapies for disease-related symptoms and complications.
Studies focus on improving quality of life and managing complications in patients with advanced kidney disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
